抗核抗体阴性的皮肤型红斑狼疮患者仍可符合SLE分类标准
该研究基于301例经活检证实的皮肤型红斑狼疮(CLE)患者数据库,分析抗核抗体(ANA)阴性者中符合ACR和/或SLICC系统性红斑狼疮(SLE)分类标准的比例。结果显示111例ANA阴性患者中20例(18.0%)符合SLE标准,提示ANA并非系统性疾病的必备标志,制定SLE分类标准时应考虑此事实。
要点
- 活检证实的CLE患者中36.9%为ANA阴性,其中18.0%仍符合SLE分类标准。
- ANA阴性或波动且符合SLE标准者中84.4%有皮肤以外至少1个器官系统受累。
- ANA并非SLE的必备标志,制定分类标准用于临床试验时需考虑ANA阴性情况。
核心结论
- ANA并非在所有系统性红斑狼疮患者中存在,制定SLE分类标准用于临床试验时应考虑ANA阴性的情况。
研究设计与样本
- 基于301例经活检证实的皮肤型红斑狼疮患者数据库,检索ANA阴性结果及是否符合ACR和/或SLICC的SLE分类标准。
主要发现
- 301例活检证实CLE且已知ANA的患者中,111例ANA阴性(36.9%),27例ANA波动(33.3%)。
- 20例ANA阴性患者符合SLE标准(18.0%),12例ANA波动患者符合SLE标准(44.4%)。
- ANA阴性或波动且符合SLE标准的32例患者中,27例有皮肤以外至少1个器官系统受累(84.4%),13例有至少2个器官系统受累(40.6%)。
临床怎么用
- 对ANA阴性的皮肤型红斑狼疮患者,仍应评估皮肤以外器官系统受累以判断是否符合SLE分类标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic lupus erythematosus (SLE) is a disorder that is heterogeneous and can be difficult to diagnose. One hallmark of the disease is the presence of antinuclear antibodies (ANAs), a feature that has been incorporated into multiple classification criteria over the years. In this study, we used a database of patients with cutaneous lupus erythematosus (CLE) to determine how many had a negative ANA and met criteria for SLE using the American College of Rheumatology (ACR) and/or Systemic Lupus International Collaborating Clinics (SLICC) criteria. METHODS: We used a database of 301 biopsy-proven CLE patients that contained information including ANA status and the presence of features of SLE. The database was searched for patients who had a negative ANA result and whether or not they met SLE criteria using the ACR and/or SLICC criteria. RESULTS: Of the 301 patients with biopsy-proven CLE and a known ANA, 111 had a negative ANA test (36.9%) and 27 had an ANA test that fluctuated (33.3%). In all, 20 ANA-negative patients met SLE criteria (18.0%), and 12 patients with a fluctuating ANA test met SLE criteria (44.4%). Of all patients who had either a negative or fluctuating ANA result and who met criteria for SLE (n = 32), 27 patients had involvement of ≥1 organ system other than skin (84.4%), and 13 patients had involvement of ≥2 organ systems other than skin (40.6%). CONCLUSION: Our results show that an ANA is not always present in patients with systemic disease. This fact should be taken into consideration when devising SLE classification criteria to be used for clinical trials.
引用
- Tarazi M, Gaffney RG, Kushner CJ, et al. Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2019. PMID: 31058462. doi:10.1002/acr.23916
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。